Synovial fibroblasts in 2017

RMD Open

Volumn 3, Issue 2, 2017, Pages

  Ospelt, Caroline ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYTOKINE; FIBRONECTIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MICRORNA; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR;

B LYMPHOCYTE; CARTILAGE DEGENERATION; CELL ACTIVATION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COCULTURE; DNA METHYLATION; ENDOTHELIUM CELL; EPIGENETICS; EXOSOME; GENE IDENTIFICATION; GENOME IMPRINTING; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; IN VIVO STUDY; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; NONHUMAN; OSTEOCLAST; PHENOTYPE; PROTEIN BINDING; REVIEW; RHEUMATOID ARTHRITIS; STROMA CELL; SYNOVIAL FIBROBLAST; SYNOVIAL FLUID; T LYMPHOCYTE; TERTIARY LYMPHOID STRUCTURE;

EID: 85032853779     PISSN: None     EISSN: 20565933     Source Type: Journal    
DOI: 10.1136/rmdopen-2017-000471     Document Type: Review

References (118)

1. Owens BM, Steevels TA, Dudek M, et al. CD90(+) stromal cells are non-professional innate immune effectors of the human colonic mucosa. Front Immunol 2013;4:307.
2. Ospelt C, Brentano F, Rengel Y, et al. Overexpression of tolllike receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: Toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum 2008;58:3684-92.
3. Umetsu DT, Katzen D, Jabara HH, et al. Antigen presentation by human dermal fibroblasts: Activation of resting T lymphocytes. J Immunol 1986;136:440-5.
4. Wassenaar A, Snijders A, Abraham-Inpijn L, et al. Antigenpresenting properties of gingival fibroblasts in chronic adult periodontitis. Clin Exp Immunol 1997;110:277-84.
5. Uehara A, Takada H. Functional TLRs and NODs in human gingival fibroblasts. J Dent Res 2007;86:249-54.
6. Buckingham RB, Castor CW. The effect of bacterial products on synovial fibroblast function: hypermetabolic changes induced by endotoxin. J Clin Invest 1972;51:1186-94.
7. Rosengren S, Boyle DL, Firestein GS. Acquisition, culture, and phenotyping of synovial fibroblasts. Methods Mol Med 2007;135:365-75.
8. Neumann E, Riepl B, Knedla A, et al. Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther 2010;12:R83.
9. Zimmermann T, Kunisch E, Pfeiffer R, et al. Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture-primary culture cells markedly differ from fourthpassage cells. Arthritis Res 2001;3:72-6.
10. Carrión M, Juarranz Y, Pérez-García S, et al. RNA sensors in human osteoarthritis and rheumatoid arthritis synovial fibroblasts: immune regulation by vasoactive intestinal peptide. Arthritis Rheum 2011;63:1626-36.
11. Brentano F, Schorr O, Gay RE, et al. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis Rheum 2005;52:2656-65.
12. Jones DS, Jenney AP, Swantek JL, et al. Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation. Nat Chem Biol 2017;13:38-45.
13. Okamura Y, Watari M, Jerud ES, et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001;276:10229-33.
14. Kokkola R, Sundberg E, Ulfgren AK, et al. High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis. Arthritis Rheum 2002;46:2598-603.
15. Hasegawa M, Nakoshi Y, Muraki M, et al. Expression of large tenascin-C splice variants in synovial fluid of patients with rheumatoid arthritis. J Orthop Res 2007;25:563-8.
16. Huang QQ, Sobkoviak R, Jockheck-Clark AR, et al. Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling. J Immunol 2009;182:4965-73.
17. Connolly M, Rooney PR, McGarry T, et al. Acute serum amyloid A is an endogenous TLR2 ligand that mediates inflammatory and angiogenic mechanisms. Ann Rheum Dis 2016;75:1392-8.
18. Warger T, Hilf N, Rechtsteiner G, et al. Interaction of TLR2 and TLR4 ligands with the N-Terminal domain of Gp96 amplifies innate and adaptive immune responses. J Biol Chem 2006;281:22545-53.
19. Hreggvidsdottir HS, Ostberg T, Wähämaa H, et al. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol 2009;86:655-62.
20. Ebid R, Lichtnekert J, Anders H-J. Hyaluronan is not a ligand but a regulator of toll-like receptor signaling in mesangial cells: role of extracellular matrix in innate immunity. ISRN Nephrol 2014;2014:1-11.
21. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001;167:2887-94.
22. Sokolove J, Zhao X, Chandra PE, et al. Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcã receptor. Arthritis Rheum 2011;63:53-62.
23. Sanchez-Pernaute O, Filkova M, Gabucio A, et al. Citrullination enhances the pro-inflammatory response to fibrin in rheumatoid arthritis synovial fibroblasts. Ann Rheum Dis 2013;72:1400-6.
24. Xu J, Zhang X, Monestier M, et al. Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J Immunol 2011;187:2626-31.
25. Sohn DH, Rhodes C, Onuma K, et al. Local joint inflammation and histone citrullination in a murine model of the transition from preclinical autoimmunity to inflammatory arthritis. Arthritis Rheumatol 2015;67:2877-87.
26. Hatterer E, Shang L, Simonet P, et al. A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease. Arthritis Res Ther 2016;18:224.
27. Skriner K, Adolph K, Jungblut PR, et al. Association of citrullinated proteins with synovial exosomes. Arthritis Rheum 2006;54:3809-14.
28. Manček-Keber M, Frank-Bertoncelj M, Hafner-Bratkovič I, et al. Tolllike receptor 4 senses oxidative stress mediated by the oxidation of phospholipids in extracellular vesicles. Sci Signal 2015;8:ra60.
29. Berckmans RJ, Nieuwland R, Kraan MC, et al. Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes. Arthritis Res Ther 2005;7:R536-44.
30. Messer L, Alsaleh G, Freyssinet JM, et al. Microparticle-induced release of B-lymphocyte regulators by rheumatoid synoviocytes. Arthritis Res Ther 2009;11:R40.
31. Jöngel A, Distler O, Schulze-Horsel U, et al. Microparticles stimulate the synthesis of prostaglandin E(2) via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1. Arthritis Rheum 2007;56:3564-74.
32. Paludan SR, Bowie AG. Immune sensing of DNA. Immunity 2013;38:870-80.
33. Kyburz D, Rethage J, Seibl R, et al. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by tolllike receptor signaling. Arthritis Rheum 2003;48:642-50.
34. Hu F, Mu R, Zhu J, et al. Hypoxia and hypoxia-inducible factor-1á provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis. Ann Rheum Dis 2014;73:928-36.
35. Carmona-Rivera C, Carlucci PM, Moore E, et al. Synovial fibroblastneutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis. Sci Immunol 2017;2:eaag3358.
36. Boots AM, Wimmers-Bertens AJ, Rijnders AW. Antigen-presenting capacity of rheumatoid synovial fibroblasts. Immunology 1994;82:268-74.
37. Burmester GR, Dimitriu-Bona A, Waters SJ, et al. Identification of three major synovial lining cell populations by monoclonal antibodies directed to Ia antigens and antigens associated with monocytes/macrophages and fibroblasts. Scand J Immunol 1983;17:69-82.
38. Tran CN, Davis MJ, Tesmer LA, et al. Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes. Arthritis Rheum 2007;56:1497-506.
39. Pierer M, Rethage J, Seibl R, et al. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J Immunol 2004;172:1256-65.
40. Bombardieri M, Kam NW, Brentano F, et al. A BAFF/APRILdependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells. Ann Rheum Dis 2011;70:1857-65.
41. Ospelt C, Brentano F, Jöngel A, et al. Expression, regulation, and signaling of the pattern-recognition receptor nucleotidebinding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2009;60:355-63.
42. Yokota K, Miyazaki T, Hemmatazad H, et al. The pattern-recognition receptor nucleotide-binding oligomerization domain-containing protein 1 promotes production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2012;64:1329-37.
43. Klein K, Frank-Bertoncelj M, Karouzakis E, et al. The epigenetic architecture at gene promoters determines cell type-specific LPS tolerance. J Autoimmun 2017;83:122-33.
44. Lefèvre S, Schwarz M, Meier FMP, et al. Disease-specific effects of matrix and growth factors on adhesion and migration of rheumatoid synovial fibroblasts. J Immunol 2017;198:4588-95.
45. Ehling A, Schäffler A, Herfarth H, et al. The potential of adiponectin in driving arthritis. J Immunol 2006;176:4468-78.
46. Boström EA, Svensson M, Andersson S, et al. Resistin and insulin/insulin-like growth factor signaling in rheumatoid arthritis. Arthritis Rheum 2011;63:2894-904.
47. Meier FM, Frommer KW, Peters MA, et al. Visfatin/pre-B-cell colony-enhancing factor (PBEF), a proinflammatory and cell motility-changing factor in rheumatoid arthritis. J Biol Chem 2012;287:28378-85.
48. Haniffa MA, Wang XN, Holtick U, et al. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol 2007;179:1595-604.
49. Jones S, Horwood N, Cope A, et al. The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J Immunol 2007;179:2824-31.
50. Tykocinski LO, Lauffer AM, Bohnen A, et al. Synovial fibroblasts selectively suppress Th1 cell responses through IDO1-mediated tryptophan catabolism. J Immunol 2017;198:3109-17.
51. Miranda-Carús ME, Balsa A, Benito-Miguel M, et al. IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-Talk in rheumatoid arthritis: effect of methotrexate. J Immunol 2004;173:1463-76.
52. Cho ML, Yoon CH, Hwang SY, et al. Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients: cross-Talk between T cells and synovial fibroblasts. Arthritis Rheum 2004;50:776-84.
53. Scott S, Pandolfi F, Kurnick JT. Fibroblasts mediate T cell survival: A proposed mechanism for retention of primed T cells. J Exp Med 1990;172:1873-6.
54. Salmon M, Scheel-Toellner D, Huissoon AP, et al. Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest 1997;99:439-46.
55. Krzesicki RF, Fleming WE, Winterrowd GE, et al. T lymphocyte adhesion to human synovial fibroblasts. role of cytokines and the interaction between intercellular adhesion molecule 1 and CD11a/CD18. Arthritis Rheum 1991;34:1245-53.
56. Brunmark A, O'Rourke AM. Augmentation of mature CD4+ T cell responses to isolated antigenic class II proteins by fibronectin and intercellular adhesion molecule-1. J Immunol 1997;159:1676-85.
57. Labuda T, Wendt J, Hedlund G, et al. ICAM-1 costimulation induces IL-2 but inhibits IL-10 production in superantigen-Activated human CD4+ T cells. Immunology 1998;94:496-502.
58. Moingeon P, Chang HC, Wallner BP, et al. CD2-mediated adhesion facilitates T lymphocyte antigen recognition function. Nature 1989;339:312-4.
59. Hassan NJ, Simmonds SJ, Clarkson NG, et al. CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76. Mol Cell Biol 2006;26:6727-38.
60. Yamamura Y, Gupta R, Morita Y, et al. Effector function of resting T cells: Activation of synovial fibroblasts. J Immunol 2001;166:2270-5.
61. Tran CN, Lundy SK, White PT, et al. Molecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-Alpha on cytokine-Activated T cells. Am J Pathol 2007;171:1588-98.
62. Dennis G, Holweg CT, Kummerfeld SK, et al. Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. Arthritis Res Ther 2014;16:R90.
63. Pitzalis C, Kelly S, Humby F. New learnings on the pathophysiology of RA from synovial biopsies. Curr Opin Rheumatol 2013;25:334-44.
64. Scheel T, Gursche A, Zacher J, et al. V-region gene analysis of locally defined synovial B and plasma cells reveals selected B cell expansion and accumulation of plasma cell clones in rheumatoid arthritis. Arthritis Rheum 2011;63:63-72.
65. Humby F, Bombardieri M, Manzo A, et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 2009;6:e1.
66. Pickens SR, Chamberlain ND, Volin MV, et al. Characterization of CCL19 and CCL21 in rheumatoid arthritis. Arthritis Rheum 2011;63:914-22.
67. Bombardieri M, Lewis M, Pitzalis C. Ectopic lymphoid neogenesis in rheumatic autoimmune diseases. Nat Rev Rheumatol 2017;13:141-54.
68. Takayanagi H, Iizuka H, Juji T, et al. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 2000;43:259-69.
69. Harada S, Yamamura M, Okamoto H, et al. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum 1999;42:1508-16.
70. Burger JA, Zvaifler NJ, Tsukada N, et al. Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1-And CD106 (VCAM-1)-dependent mechanism. J Clin Invest 2001;107:305-15.
71. Ohata J, Zvaifler NJ, Nishio M, et al. Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-Activating factor of the TNF family in response to proinflammatory cytokines. J Immunol 2005;174:864-70.
72. Thurlings RM, Wijbrandts CA, Bennink RJ, et al. Monocyte scintigraphy in rheumatoid arthritis: The dynamics of monocyte migration in immune-mediated inflammatory disease. PLoS One 2009;4:e7865.
73. Misharin AV, Cuda CM, Saber R, et al. Nonclassical Ly6C(-) monocytes drive the development of inflammatory arthritis in mice. Cell Rep 2014;9:591-604.
74. Liddiard K, Taylor PR. Understanding local macrophage phenotypes in disease: shape-shifting macrophages. Nat Med 2015;21:119-20.
75. Darrieutort-Laffite C, Boutet MA, Chatelais M, et al. IL-1â and TNFá promote monocyte viability through the induction of GM-CSF expression by rheumatoid arthritis synovial fibroblasts. Mediators Inflamm 2014;2014:1-10.
76. Kiener HP, Watts GF, Cui Y, et al. Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in threedimensional organ culture. Arthritis Rheum 2010;62:742-52.
77. Donlin LT, Jayatilleke A, Giannopoulou EG, et al. Modulation of TNF-induced macrophage polarization by synovial fibroblasts. J Immunol 2014;193:2373-83.
78. Korb-Pap A, Stratis A, Möhlenberg K, et al. Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritis. Ann Rheum Dis 2012;71:1004-11.
79. Hillen J, Geyer C, Heitzmann M, et al. Structural cartilage damage attracts circulating rheumatoid arthritis synovial fibroblasts into affected joints. Arthritis Res Ther 2017;19:40.
80. Lefèvre S, Knedla A, Tennie C, et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 2009;15:1414-20.
81. Peters MA, Wendholt D, Strietholt S, et al. The loss of á2â1 integrin suppresses joint inflammation and cartilage destruction in mouse models of rheumatoid arthritis. Arthritis Rheum 2012;64:1359-68.
82. Afratis NA, Nikitovic D, Multhaupt HA, et al. Syndecans-key regulators of cell signaling and biological functions. Febs J 2017;284:27-41.
83. Lowin T, Straub RH, Neumann E, et al. Glucocorticoids increase alpha5 integrin expression and adhesion of synovial fibroblasts but inhibit ERK signaling, migration, and cartilage invasion. Arthritis Rheum 2009;60:3623-32.
84. Rinaldi N, Schwarz-Eywill M, Weis D, et al. Increased expression of integrins on fibroblast-like synoviocytes from rheumatoid arthritis in vitro correlates with enhanced binding to extracellular matrix proteins. Ann Rheum Dis 1997;56:45-51.
85. Mostafavi-Pour Z, Askari JA, Parkinson SJ, et al. Integrin-specific signaling pathways controlling focal adhesion formation and cell migration. J Cell Biol 2003;161:155-67.
86. Vartio T, Vaheri A, Von Essen R, et al. Fibronectin in synovial fluid and tissue in rheumatoid arthritis. Eur J Clin Invest 1981;11:207-12.
87. Shiozawa K, Shiozawa S, Shimizu S, et al. Fibronectin on the surface of articular cartilage in rheumatoid arthritis. Arthritis Rheum 1984;27:615-22.
88. Shiozawa S, Yoshihara R, Kuroki Y, et al. Pathogenic importance of fibronectin in the superficial region of articular cartilage as a local factor for the induction of pannus extension on rheumatoid articular cartilage. Ann Rheum Dis 1992;51:869-73.
89. Brown RA, Jones KL. The synthesis and accumulation of fibronectin by human articular cartilage. J Rheumatol 1990;17:65-72.
90. Rengel Y, Ospelt C, Gay S. Proteinases in the joint: clinical relevance of proteinases in joint destruction. Arthritis Res Ther 2007;9:221.
91. Araki Y, Tsuzuki Wada T, Aizaki Y, et al. Histone methylation and STAT-3 differentially regulate interleukin-6-induced matrix metalloproteinase gene activation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheumatol 2016;68:1111-23.
92. Elshabrawy HA, Chen Z, Volin MV, et al. The pathogenic role of angiogenesis in rheumatoid arthritis. Angiogenesis 2015;18:433-48.
93. Ng CT, Biniecka M, Kennedy A, et al. Synovial tissue hypoxia and inflammation in vivo. Ann Rheum Dis 2010;69:1389-95.
94. Biniecka M, Canavan M, McGarry T, et al. Dysregulated bioenergetics: A key regulator of joint inflammation. Ann Rheum Dis 2016;75:2192-200.
95. Zimmermann-Geller B, Köppert S, Fischer S, et al. Influence of extracellular RNAs, released by rheumatoid arthritis synovial fibroblasts, on their adhesive and invasive properties. J Immunol 2016;197:2589-97.
96. McGettrick HM, Smith E, Filer A, et al. Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells. Eur J Immunol 2009;39:113-25.
97. Lally F, Smith E, Filer A, et al. A novel mechanism of neutrophil recruitment in a coculture model of the rheumatoid synovium. Arthritis Rheum 2005;52:3460-9.
98. Filer A, Ward LSC, Kemble S, et al. Identification of a transitional fibroblast function in very early rheumatoid arthritis. Ann Rheum Dis 2017:annrheumdis-2017-211286.
99. Wehmeyer C, Pap T, Buckley CD, et al. The role of stromal cells in inflammatory bone loss. Clin Exp Immunol 2017;189:1-11.
100. Dankbar B, Fennen M, Brunert D, et al. Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice. Nat Med 2015;21:1085-90.
101. Möller-Ladner U, Kriegsmann J, Franklin BN, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996;149:1607-15.
102. Möller-Ladner U, Kriegsmann J, Gay RE, et al. Oncogenes in rheumatoid arthritis. Rheum Dis Clin North Am 1995;21:675-90.
103. Doody KM, Bottini N, Firestein GS. Epigenetic alterations in rheumatoid arthritis fibroblast-like synoviocytes. Epigenomics 2017;9:479-92.
104. Ospelt C, Gay S, Klein K. Epigenetics in the pathogenesis of RA. Semin Immunopathol 2017;39:409-19.
105. Cribbs A, Feldmann M, Oppermann U. Towards an understanding of the role of DNA methylation in rheumatoid arthritis: Therapeutic and diagnostic implications. Ther Adv Musculoskelet Dis 2015;7:206-19.
106. Nakano K, Whitaker JW, Boyle DL, et al. DNA methylome signature in rheumatoid arthritis. Ann Rheum Dis 2013;72:110-7.
107. Whitaker JW, Shoemaker R, Boyle DL, et al. An imprinted rheumatoid arthritis methylome signature reflects pathogenic phenotype. Genome Med 2013;5:40.
108. de la Rica L, Urquiza JM, Gómez-Cabrero D, et al. Identification of novel markers in rheumatoid arthritis through integrated analysis of DNA methylation and microRNA expression. J Autoimmun 2013;41:6-16.
109. Karouzakis E, Gay RE, Michel BA, et al. DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2009;60:3613-22.
110. Karouzakis E, Gay RE, Gay S, et al. Increased recycling of polyamines is associated with global DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2012;64:1809-17.
111. Angiolilli C, Baeten DL, Radstake TR, et al. The acetyl code in rheumatoid arthritis and other rheumatic diseases. Epigenomics 2017;9:447-61.
112. Churov AV, Oleinik EK, Knip M. MicroRNAs in rheumatoid arthritis: Altered expression and diagnostic potential. Autoimmun Rev 2015;14:1029-37.
113. Kolarz B, Majdan M. Epigenetic aspects of rheumatoid arthritis: contribution of non-coding RNAs. Semin Arthritis Rheum 2017;46:724-31.
114. Frank-Bertoncelj M, Trenkmann M, Klein K, et al. Epigeneticallydriven anatomical diversity of synovial fibroblasts guides jointspecific fibroblast functions. Nat Commun 2017;8:14852.
115. Ai R, Hammaker D, Boyle DL, et al. Joint-specific DNA methylation and transcriptome signatures in rheumatoid arthritis identify distinct pathogenic processes. Nat Commun 2016;7:11849.
116. Lee DM, Kiener HP, Agarwal SK, et al. Cadherin-11 in synovial lining formation and pathology in arthritis. Science 2007;315:1006-10.
117. Croft AP, Naylor AJ, Marshall JL, et al. Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilage. Arthritis Res Ther 2016;18:270.
118. Maia M, de Vriese A, Janssens T, et al. CD248 and its cytoplasmic domain: A therapeutic target for arthritis. Arthritis Rheum 2010;62:3595-606.